EX-32.1 4 ex32_1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Quarterly Report of American CryoStem Corporation (the “Company”), on Form 10-Q for the nine months ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, John Arnone, Chief Executive Officer of the registrant and Anthony Dudzinski, Principal Financial Officer of the registrant, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)Such Quarterly Report on Form 10-Q for the three months ended December 31, 2021 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in such Quarterly Report on Form 10-Q for the three months ended December 31, 2021 fairly presents, in all material respects, the financial condition and results of operations of the Company.
February 22, 2022 By: /s/ John Arnone  
    John Arnone  
    Chief Executive Officer  
   

American CryoStem Corporation

  
       
February 22, 2022 By: /s/ Anthony Dudzinski  
    Anthony Dudzinski  
    Chief Principal Officer  
   

American CryoStem Corporation

  
43